NL-OMON20303
Completed
Not Applicable
Feasibility of ultra high field 7.0 Tesla MRIfor the detection of breast cancer.
niversity Medical Center Utrecht (UMCU)Visiting address-----------------------Heidelberglaan 1003584 CX UtrechtThe NetherlandsPostal address---------------------Room E01.132PO Box 855003508 GA UtrechtThe NetherlandsPhone: +31 (0)88 75 555 550 sites20 target enrollmentTBD
ConditionsBreast tumorBreast neoplasm
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast tumorBreast neoplasm
- Sponsor
- niversity Medical Center Utrecht (UMCU)Visiting address-----------------------Heidelberglaan 1003584 CX UtrechtThe NetherlandsPostal address---------------------Room E01.132PO Box 855003508 GA UtrechtThe NetherlandsPhone: +31 (0)88 75 555 55
- Enrollment
- 20
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. 18 years or older;
- •2\. Female patients;
Exclusion Criteria
- •1\. Any prior surgery or radiotherapy to the ipsilateral breast;
- •2\. Karnofsky score \<\= 70;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Feasibility of ultra high field 7.0 Tesla MRI for the detection of breast cancerbreast cancerbreast neoplasm10006291NL-OMON34075niversitair Medisch Centrum Utrecht20
Withdrawn
Not Applicable
Feasibility of ultra high field 7.0. Tesla MR Spectroscopy for breast cancer detection and monitoring of neo-adjuvant chemotherapy efficacyNL-OMON35742niversitair Medisch Centrum Utrecht30
Completed
Not Applicable
Feasibility of ultra high field 7.0 Tesla MR Spectroscopy for monitoring neo-adjuvant therapy efficacy.breast cancerbreast neoplasm10006291NL-OMON38209niversitair Medisch Centrum Utrecht15
Recruiting
Not Applicable
Evaluation of Ultrahigh-Field-MRI at 7 Tesla for Imaging of ischemic lesions, carotid plaque morphology and brain perfusion - 7 UPI63.9I65.2Cerebral infarction, unspecifiedOcclusion and stenosis of carotid arteryDRKS00003193Charité Campus Charité Mitte100
Recruiting
Not Applicable
Feasibility of ultra high field 7.0 Tesla MR Spectroscopy for monitoring neo-adjuvant therapy efficacybreast cancerneoadjuvant therapyborstkankerneo-adjuvante therapyNL-OMON25351MC Utrecht15